Article Details

Debiopharm and Genome & Company Reach Agreement for Potential First-In Class ... - Morningstar

Retrieved on: 2024-06-03 12:56:42

Tags for this article:

Click the tags to see associated articles and topics

Debiopharm and Genome & Company Reach Agreement for Potential First-In Class ... - Morningstar. View article details on hiswai:

Excerpt

... monoclonal antibody, a stable linker and one ... We recognized that Genome's innovative antibodies ... antibodies as stand-alone therapy and antibody ...

Article found on: www.morningstar.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up